![Prognostic factors in renal cell carcinoma patients treated with sorafenib: results from the Czech registry | SpringerLink Prognostic factors in renal cell carcinoma patients treated with sorafenib: results from the Czech registry | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11523-014-0343-8/MediaObjects/11523_2014_343_Fig1_HTML.gif)
Prognostic factors in renal cell carcinoma patients treated with sorafenib: results from the Czech registry | SpringerLink
Antiplatelet therapy in patients after an acute coronary syndrome: Comparison of the Czech and Slovak Republics Results of the A
![Ostrizkova LENKA | University Hospital Brno, Brno | Department of Internal Medicine, Hematology and Oncology Ostrizkova LENKA | University Hospital Brno, Brno | Department of Internal Medicine, Hematology and Oncology](https://i1.rgstatic.net/ii/profile.image/526106773200897-1502445037247_Q512/Ostrizkova-Lenka.jpg)